Over 90 Total Lots Up For Auction at One Location - WA 04/08

Q&A with Jeff Bordok, CEO of Advanced Particle Therapy

by Loren Bonner, DOTmed News Online Editor | January 11, 2013
From the January 2013 issue of HealthCare Business News magazine


DMBN: What are some of the highlights of this year’s show in your opinion?
Bordok:
I think that attendees will enjoy seeing the design and technology in the Scripps Proton Therapy Center. The discussions about how other institutions can achieve their proton therapy goals will also be of interest.

DMBN: What are some of the trends you’re seeing in the field and some of the future challenges for proton therapy?
Bordok:
As more proton centers open and especially with those operated by leading cancer care centers and Comprehensive Cancer Center designated operators, sharing clinical data and patient treatment successes become very important. APT’s clinical partners meet at least twice a year to plan for this data sharing to expand on the wonderful treatment benefits proton therapy offers. Proton therapy has been around clinically for more than 20 years but with a limited number of centers. Therefore, there has only been limited beam time for patient treatment. This has restricted the number of patients that can take advantage of this treatment. As more centers come online, this will equate to more beam time and more patients will be treated. By keeping most patients monitored by managed treatment protocols, I feel we will also see improved uses of protons for treating cancer. Pencil beam scanning and IMPT are the most immediate improvements.

Back to HCB News

You Must Be Logged In To Post A Comment